Why the study?
Does the addition of high dose corticosteroids resolve recurrent giant cell myocarditis in a transplanted heart?
Does the addition of high dose corticosteroids resolve recurrent giant cell myocarditis in a transplanted heart?
High dose corticosteroids can effectively treat recurrent giant cell myocarditis in a transplanted heart despite routine immunosuppression.
Answers are grounded in this paper and cite their sources.
May support high-dose corticosteroids for recurrent post-transplant giant cell myocarditis; hypothesis-generating and requires prospective confirmation before practice change.
A 35-year-old man developed giant cell myocarditis resulting in severe congestive cardiac failure. He needed urgent orthotopic cardiac transplantation despite maximal doses of inotropes and augmentation with an intra-aortic balloon pump. The patient presented with rhythm disturbances and echocardiographically diminished ventricular function at subsequent follow-up. Biopsies then taken revealed recurrence of myocarditis in the transplanted heart. Investigations revealed no obvious cause for the myocardial granulomas nor any evidence of systemic granulomatous disease. The patient received, in addition to maintenance cyclosporin A and azathioprine, high doses of corticosteroids which resulted in complete resolution of the inflammatory process and no recurrence has been detected to date. This case shows that giant cell myocarditis can recur in the transplanted heart despite routine immunosuppression with azathioprine and cyclosporin A and that additional treatment with high dose corticosteroids is effective in causing regression of the inflammatory process.
No takes yet. Share an insight, caveat, or question.
Kong et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: